RISPERDAL AND
BRAND AND
GENERIC
RISPERDAL AND
ZYPREXA
CAUSED BREAST CANCER, SAYS SUIT
By Martha Rosenberg
Drug giants Johnson & Johnson or J & J( who marketed Risperdal) and Eli Lilly( who marketed Zyprexa) are among the suit’ s major defendants along with J & J subsidiary Janssen Pharmaceuticals( who marketed Risperdal) and Lilly German partner Cheplapharm Arzneimittel Gmbh.
Bridgett Brown, a resident of California, developed breast cancer from using brand-name and generic versions of the antipsychotics Risperdal( risperidone) and Zyprexa( olanzapine) says a lawsuit from the Wisner Baum law firm.
Neither Brown or her two prescribing physicians knew or“ had reason to know” that the drugs could cause breast cancer since the drug manufacturers“ obfuscated and disclaimed such risks while promoting these dangerous, expensive drugs over safer, more affordable alternatives.”
Brown suffered disfigurement, physical injury, pain and emotional distress and demands a jury trial, says the suit. Drug giants Johnson & Johnson or J & J( who marketed Risperdal) and Eli Lilly( who marketed Zyprexa) are among the suit’ s major defendants along with J & J subsidiary Janssen Pharmaceuticals( who marketed Risperdal) and Lilly German partner Cheplapharm Arzneimittel Gmbh.
40 x The Trial Lawyer